PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Target ANGPTL4 289 1 0.00 -1.00 0.00 0.70
FABP3 134 Target Target ANGPTL4 289 2 0.01 -0.99 0.01 0.73
ANGPT1 81 Target Target ANGPT2 105 42 0.46 -0.54 0.52 0.94
Shock 134,031 Disease Target ANGPT2 105 1 0.00 -1.00 0.01 0.54
Phospholipase A2 13,400 Target Target ANGPT2 105 1 0.00 -1.00 0.01 0.59
Bladder Cancer 21,509 Disease Target ANGPT2 105 1 0.00 -1.00 0.01 0.58
Obesity 138,233 Disease Target ANGPT2 105 1 0.00 -1.00 0.01 0.54
Glyceraldehyde 3-Phosphate Dehydrogenase 5,919 Target Target ANGPT2 105 1 0.00 -1.00 0.01 0.61
Cerebral Edema 3,889 Disease Target ANGPT2 105 1 0.00 -1.00 0.01 0.62
Cox-2 21,583 Target Target ANGPT2 105 1 0.00 -1.00 0.01 0.58
Metastatic Breast Cancer 9,288 Disease Target ANGPT2 105 1 0.00 -1.00 0.01 0.60
Carcinoma 433,099 Disease Target ANGPT2 105 7 0.00 -0.97 0.07 0.56
Collagen 138,882 Target Target ANGPT2 105 1 0.00 -1.00 0.01 0.54
Stroke 146,992 Disease Target ANGPT2 105 2 0.00 -0.99 0.02 0.55
EPHA2 532 Target Target ANGPT2 105 1 0.00 -0.99 0.01 0.69
Eotaxin 2,457 Target Target ANGPT2 105 1 0.00 -1.00 0.01 0.64
Hemorrhage 100,979 Disease Target ANGPT2 105 1 0.00 -1.00 0.01 0.54
CCL7 274 Target Target ANGPT2 105 1 0.01 -0.99 0.01 0.71
Brain Cancer 1,542 Disease Target ANGPT2 105 1 0.00 -0.99 0.01 0.65
Infection 766,637 Disease Target ANGPT2 105 2 0.00 -0.99 0.02 0.52
Prostate Cancer 71,064 Disease Target ANGPT2 105 1 0.00 -1.00 0.01 0.55
Hepatitis B 57,815 Disease Target ANGPT2 105 1 0.00 -1.00 0.01 0.56
C7 7,027 Target Target ANGPT2 105 1 0.00 -1.00 0.01 0.61
CCL5 2,002 Target Target ANGPT2 105 3 0.01 -0.98 0.03 0.68
Hepatitis 163,842 Disease Target ANGPT2 105 1 0.00 -1.00 0.01 0.53
Tremor 14,317 Disease Target ANGPT2 105 1 0.00 -1.00 0.01 0.59
Chronic Obstructive Pulmonary Disease 27,780 Disease Target ANGPT2 105 1 0.00 -1.00 0.01 0.57
Diabetes 332,602 Disease Target ANGPT2 105 4 0.00 -0.98 0.04 0.55
Endometriosis 16,342 Disease Target ANGPT2 105 2 0.00 -0.99 0.02 0.60
Colon Cancer 30,064 Disease Target ANGPT2 105 1 0.00 -1.00 0.01 0.57
Epidermal Growth Factor Receptor 24,772 Target Target ANGPT2 105 2 0.00 -0.99 0.02 0.59
CCL3 1,427 Target Target ANGPT2 105 1 0.00 -0.99 0.01 0.65
Cholesterol 182,390 Disease Target ANGPT2 105 1 0.00 -1.00 0.01 0.53
EPHB3 118 Target Target ANGPT2 105 1 0.01 -0.99 0.01 0.74
ERK1 18,374 Target Target ANGPT2 105 1 0.00 -1.00 0.01 0.58
Endostatin 1,599 Target Target ANGPT2 105 1 0.00 -0.99 0.01 0.65
ANGPTL4 289 Target Target ANGPT2 105 3 0.02 -0.98 0.03 0.75
CCL2 3,560 Target Target ANGPT2 105 3 0.00 -0.99 0.03 0.66
CXCL9 1,016 Target Target ANGPT2 105 1 0.00 -0.99 0.01 0.67
Cancer 1,053,491 Disease Target ANGPT2 105 14 0.00 -0.93 0.13 0.55
EPHB2 385 Target Target ANGPT2 105 1 0.00 -0.99 0.01 0.70
Chronic Lymphocytic Leukemia 11,642 Disease Target ANGPT2 105 1 0.00 -1.00 0.01 0.60
CD4 112,219 Target Target ANGPT2 105 2 0.00 -0.99 0.02 0.56
Osteoarthritis 36,287 Disease Target ANGPT1 81 1 0.00 -0.99 0.01 0.57
Albuminuria 6,831 Disease Target ANGPT1 81 1 0.00 -0.99 0.01 0.61
Hemorrhage 100,979 Disease Target ANGPT1 81 1 0.00 -0.99 0.01 0.55
Lichen Planus 5,287 Disease Target ANGPT1 81 1 0.00 -0.99 0.01 0.62
Prostate Cancer 71,064 Disease Target ANGPT1 81 2 0.00 -0.99 0.02 0.57
Glyceraldehyde 3-Phosphate Dehydrogenase 5,919 Target Target ANGPT1 81 1 0.00 -0.99 0.01 0.62
Carcinoma 433,099 Disease Target ANGPT1 81 5 0.00 -0.97 0.06 0.55
Obesity 138,233 Disease Target ANGPT1 81 4 0.00 -0.97 0.05 0.57
Erbb2 4,536 Target Target ANGPT1 81 1 0.00 -0.99 0.01 0.62
Diabetes 332,602 Disease Target ANGPT1 81 4 0.00 -0.97 0.05 0.55
Cancer 1,053,491 Disease Target ANGPT1 81 7 0.00 -0.96 0.09 0.54
Endostatin 1,599 Target Target ANGPT1 81 1 0.00 -0.99 0.01 0.66
Endometriosis 16,342 Disease Target ANGPT1 81 3 0.00 -0.98 0.04 0.62
Carcinoma 433,099 Disease Target AMY2B 21 1 0.00 -0.98 0.05 0.54
Obesity 138,233 Disease Target AMY2B 21 1 0.00 -0.98 0.05 0.57
Cancer 1,053,491 Disease Target AMY2B 21 3 0.00 -0.93 0.14 0.55
Diabetes 332,602 Disease Target AMY2B 21 2 0.00 -0.95 0.10 0.56
Ovarian Cancer 33,996 Disease Target AMY2B 21 1 0.00 -0.98 0.05 0.60
Antithrombin 13,773 Target Target AMY1A 13 1 0.00 -0.96 0.08 0.62
Alpha-Amylase 7,171 Target Target AMY1A 13 9 0.03 -0.55 0.69 0.70
Renin 43,456 Target Target AMY1A 13 1 0.00 -0.96 0.08 0.60
AMY2B 21 Target Target AMY1A 13 2 0.12 -0.87 0.15 0.87
Carcinoma 433,099 Disease Target AMY1A 13 1 0.00 -0.96 0.08 0.55
Lung Cancer 91,416 Disease Target AMBP 160 1 0.00 -1.00 0.01 0.54
Hypoglycemia 20,698 Disease Target AMBP 160 1 0.00 -1.00 0.01 0.57
Diabetes 332,602 Disease Target AMBP 160 22 0.00 -0.93 0.14 0.58
Glyceraldehyde 3-Phosphate Dehydrogenase 5,919 Target Target AMBP 160 1 0.00 -1.00 0.01 0.61
APOH 110 Target Target AMBP 160 1 0.01 -0.99 0.01 0.73
Myeloperoxidase 16,181 Target Target AMBP 160 2 0.00 -0.99 0.01 0.60
Obesity 138,233 Disease Target AMBP 160 1 0.00 -1.00 0.01 0.53
Carcinoma 433,099 Disease Target AMBP 160 2 0.00 -0.99 0.01 0.52
CD4 112,219 Target Target AMAC-1 19 1 0.00 -0.97 0.05 0.57
CD1A 2,739 Target Target AMAC-1 19 1 0.00 -0.97 0.05 0.66
Graft Versus Host Disease 15,741 Disease Target AMAC-1 19 1 0.00 -0.97 0.05 0.62
CD68 6,424 Target Target AMAC-1 19 1 0.00 -0.97 0.05 0.64
Benign Prostatic Hyperplasia 10,026 Disease Target ALPP 80 1 0.00 -0.99 0.01 0.60
Nausea 42,627 Disease Target ALPP 80 1 0.00 -0.99 0.01 0.57
Androgen Receptor 12,918 Target Target ALPP 80 1 0.00 -0.99 0.01 0.60
Overactive Bladder 3,492 Disease Target ALPP 80 1 0.00 -0.99 0.01 0.63
CD4 112,219 Target Target ALPP 80 1 0.00 -0.99 0.01 0.55
Miscarriages 3,138 Disease Target ALPP 80 1 0.00 -0.99 0.01 0.64
Poisoning 53,779 Disease Target ALPP 80 1 0.00 -0.99 0.01 0.56
Infection 766,637 Disease Target ALPP 80 2 0.00 -0.99 0.03 0.52
Cancer 1,053,491 Disease Target ALPP 80 5 0.00 -0.97 0.06 0.53
Ovarian Cancer 33,996 Disease Target ALPP 80 1 0.00 -0.99 0.01 0.57
Prostate Cancer 71,064 Disease Target ALPP 80 4 0.00 -0.97 0.05 0.59
Brain Injury 34,874 Disease Target ALPP 80 1 0.00 -0.99 0.01 0.57
Osteoporosis 46,215 Disease Target ALK Phos 19 2 0.00 -0.95 0.11 0.61
Anemia 81,663 Disease Target ALK Phos 19 1 0.00 -0.97 0.05 0.58
Cancer 1,053,491 Disease Target ALK Phos 19 1 0.00 -0.97 0.05 0.53
Prostate Cancer 71,064 Disease Target ALK Phos 19 1 0.00 -0.97 0.05 0.58
Poisoning 53,779 Disease Target ALK Phos 19 1 0.00 -0.97 0.05 0.59
Pneumonia 81,521 Disease Target ALK Phos 19 1 0.00 -0.97 0.05 0.58
Renal Failure 73,993 Disease Target ALK Phos 19 1 0.00 -0.97 0.05 0.58
Osteoarthritis 36,287 Disease Target ALK Phos 19 1 0.00 -0.97 0.05 0.60
Diabetes 332,602 Disease Target ALK Phos 19 1 0.00 -0.97 0.05 0.55
Back Pain 30,003 Disease Target AKT3 293 1 0.00 -1.00 0.00 0.55